Point Of Care Infectious Disease Testing Global Market Report 2025

Description

Point of care (POC) infectious disease testing involves diagnostic tests conducted at or near the location of patient care, such as in hospitals, clinics, doctor's offices, or even at home. These tests are designed to quickly and accurately detect infectious diseases, providing immediate results to support timely treatment decisions. POC tests are typically easy to use, require minimal equipment, and deliver results within minutes to hours, making them particularly useful when fast diagnosis is essential.

The primary product categories in point of care infectious disease testing are kits and reagents, as well as instruments. Kits and reagents consist of pre-prepared components used in point-of-care diagnostics to rapidly identify infectious agents through reactions with patient samples. Common technologies include lateral flow immunoassay, agglutination tests, flow-through tests, immunoconcentration assays, and molecular diagnostics, among others. The diseases tested for include human immunodeficiency virus (HIV), Clostridium difficile, hepatitis B virus, pneumonia or streptococcus-related infections, respiratory syncytial virus, human papillomavirus, influenza, and more. Point-of-care testing is utilized by various end-users, including hospitals, diagnostic centers, research and academic institutions, homecare settings, and others.

The point of care infectious disease testing market research report is one of a series of new reports from The Business Research Company that provides point of care infectious disease testing market statistics, including the point of care infectious disease testing industry global market size, regional shares, competitors with the point of care infectious disease testing market share, detailed point of care infectious disease testing market segments, market trends, and opportunities, and any further data you may need to thrive in the point of care infectious disease testing industry. This point of care infectious disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The point of care infectious disease testing market size has grown rapidly in recent years. It will grow from $4.21 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth observed in the past can be attributed to the rising demand for rapid diagnostic solutions, the increasing incidence of infectious diseases, greater healthcare awareness, higher healthcare expenditure, and the growing adoption of home care and self-testing solutions.

The point of care infectious disease testing market size is expected to see rapid growth in the next few years. It will grow to $8.02 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth expected in the forecast period is driven by the increasing demand for rapid diagnostics, the rising prevalence of infectious diseases, greater adoption in remote and resource-constrained areas, a shift toward decentralized healthcare, and supportive government initiatives and funding. Key trends in the forecast period include advancements in molecular diagnostics, development of advanced point-of-care testing devices, innovations in biosensors and detection technologies, progress in mobile health applications, and collaborative partnerships between healthcare providers and technology companies.

The increasing prevalence of contagious diseases is expected to drive the growth of the point-of-care infectious disease testing market in the future. A contagious disease is one that can spread from person to person through direct contact, airborne droplets, or other transmission methods. The growing incidence of such diseases is largely due to increased human mobility, as more people move across regions and countries, which accelerates the spread of infectious agents. Point-of-care infectious disease testing helps speed up the detection and diagnosis of contagious diseases, allowing for timely treatment and reducing the risk of transmission within communities. For example, in June 2024, the UK Health Security Agency reported that from week 40 of 2022 to week 15 of 2023, 108 NHS trusts in England recorded 1,681 critical care admissions due to confirmed influenza. In comparison, the previous flu season saw only 182 admissions across 114 trusts, which increased to 316 by week 39 of 2022. Thus, the rising number of contagious diseases is fueling the growth of the point-of-care infectious disease testing market.

Companies in the point-of-care infectious disease testing market are increasingly integrating innovative technologies such as proprietary microfluidic technology to improve test accuracy, reduce time-to-results, and enhance patient outcomes. Microfluidic technology involves specialized systems that manipulate small fluid volumes at the microscale, enabling fast, precise, and cost-effective analysis. This technology benefits point-of-care infectious disease testing by allowing rapid, on-site pathogen detection with integrated sample collection, analysis, and result output, thus enhancing diagnostic speed and accessibility without requiring centralized laboratory testing. For instance, in June 2023, Sysmex Corporation, a diagnostics company based in Japan, launched the PA-100 AST System in Europe, the first point-of-care solution for directly detecting antimicrobial susceptibility. Using advanced microfluidic technology, this system enables quick identification of bacterial infections and assessment of antimicrobial effectiveness, significantly reducing processing times compared to conventional methods. It includes a compact, desktop-sized analyzer and single-use sample cartridges, making it ideal for near-patient settings such as primary care clinics. Designed to facilitate faster and more accurate antimicrobial therapy decisions, this system contributes to the global fight against antimicrobial resistance by improving diagnostic efficiency.

In July 2024, F. Hoffmann-La Roche AG, a Swiss pharmaceutical company, acquired LumiraDx's point-of-care technology for $295 million. This acquisition allows Roche to expand access to decentralized diagnostic testing by incorporating LumiraDx's versatile point-of-care platform into its diagnostics portfolio. This integration aims to provide timely and actionable results across primary care and underserved healthcare settings. LumiraDx, a U.S.-based medical equipment manufacturer, specializes in point-of-care infectious disease testing.

Major players in the point of care infectious disease testing market are Cardinal Health, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, bioMerieux Societe Anonyme, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin Societa per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Societe Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, and bioLytical Laboratories Inc.

North America was the largest region in the point of care infectious disease testing market in 2024. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in point-of-care infectious disease testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point-of-care infectious disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care infectious disease testing market consists of revenues earned by entities by providing services such as rapid diagnostic testing, disease screening, and onsite sample analysis for infectious conditions. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care infectious disease testing market also includes sales of handheld analyzers, lateral flow assays, molecular testing devices, and related consumables used for the immediate detection of infectious diseases. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care Infectious Disease Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point of care infectious disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care infectious disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point of care infectious disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Kits And Reagents; Instruments
2) By Technology: Lateral Flow Immunoassay; Agglutination Test; Flow-through Test Or Immunoconcentration Assay; Molecular Diagnostics; Other Technologies
3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing; Clostridium Difficile Point-of-Care Testing; Hepatitis B Virus Point-of-Care Testing; Pneumonia or Streptococcus Associated Infections; Respiratory Syncytial Virus Point-of-Care Testing; Human Papillomavirus Point-of-Care Testing; Influenza Or Flu Point-of-Care Testing; Other Diseases
4) By End Use: Hospitals; Diagnostic Centers; Research and Academic Institutes; Homecare Settings; Other End Users
Subsegments:
1) By Kits And Reagents: Test Kits; Reagents
2) By Instruments: Portable Devices; Automated Analyzers
Companies Mentioned: Cardinal Health; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35573

1. Executive Summary

2. Point Of Care Infectious Disease Testing Market Characteristics

3. Point Of Care Infectious Disease Testing Market Trends And Strategies

4. Point Of Care Infectious Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Point Of Care Infectious Disease Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Point Of Care Infectious Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Point Of Care Infectious Disease Testing Market Growth Rate Analysis
5.4. Global Point Of Care Infectious Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Point Of Care Infectious Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Point Of Care Infectious Disease Testing Total Addressable Market (TAM)

6. Point Of Care Infectious Disease Testing Market Segmentation

6.1. Global Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Kits And Reagents
Instruments
6.2. Global Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lateral Flow Immunoassay
Agglutination Test
Flow-Through Test Or Immunoconcentration Assay
Molecular Diagnostics
Other Technologies
6.3. Global Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Immunodeficiency Virus Point-Of-Care Testing
Clostridium Difficile Point-Of-Care Testing
Hepatitis B Virus Point-Of-Care Testing
Pneumonia Or Streptococcus Associated Infections
Respiratory Syncytial Virus Point-Of-Care Testing
Human Papillomavirus Point-Of-Care Testing
Influenza Or Flu Point-Of-Care Testing
Other Diseases
6.4. Global Point Of Care Infectious Disease Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Research And Academic Institutes
Homecare Settings
Other End Users
6.5. Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Test Kits
Reagents
6.6. Global Point Of Care Infectious Disease Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Portable Devices
Automated Analyzers

7. Point Of Care Infectious Disease Testing Market Regional And Country Analysis

7.1. Global Point Of Care Infectious Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Point Of Care Infectious Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point Of Care Infectious Disease Testing Market

8.1. Asia-Pacific Point Of Care Infectious Disease Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point Of Care Infectious Disease Testing Market

9.1. China Point Of Care Infectious Disease Testing Market Overview
9.2. China Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point Of Care Infectious Disease Testing Market

10.1. India Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point Of Care Infectious Disease Testing Market

11.1. Japan Point Of Care Infectious Disease Testing Market Overview
11.2. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point Of Care Infectious Disease Testing Market

12.1. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point Of Care Infectious Disease Testing Market

13.1. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point Of Care Infectious Disease Testing Market

14.1. South Korea Point Of Care Infectious Disease Testing Market Overview
14.2. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point Of Care Infectious Disease Testing Market

15.1. Western Europe Point Of Care Infectious Disease Testing Market Overview
15.2. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point Of Care Infectious Disease Testing Market

16.1. UK Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point Of Care Infectious Disease Testing Market

17.1. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point Of Care Infectious Disease Testing Market

18.1. France Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point Of Care Infectious Disease Testing Market

19.1. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point Of Care Infectious Disease Testing Market

20.1. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point Of Care Infectious Disease Testing Market

21.1. Eastern Europe Point Of Care Infectious Disease Testing Market Overview
21.2. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point Of Care Infectious Disease Testing Market

22.1. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point Of Care Infectious Disease Testing Market

23.1. North America Point Of Care Infectious Disease Testing Market Overview
23.2. North America Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point Of Care Infectious Disease Testing Market

24.1. USA Point Of Care Infectious Disease Testing Market Overview
24.2. USA Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point Of Care Infectious Disease Testing Market

25.1. Canada Point Of Care Infectious Disease Testing Market Overview
25.2. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point Of Care Infectious Disease Testing Market

26.1. South America Point Of Care Infectious Disease Testing Market Overview
26.2. South America Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point Of Care Infectious Disease Testing Market

27.1. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point Of Care Infectious Disease Testing Market

28.1. Middle East Point Of Care Infectious Disease Testing Market Overview
28.2. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point Of Care Infectious Disease Testing Market

29.1. Africa Point Of Care Infectious Disease Testing Market Overview
29.2. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Point Of Care Infectious Disease Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point Of Care Infectious Disease Testing Market Competitive Landscape And Company Profiles

30.1. Point Of Care Infectious Disease Testing Market Competitive Landscape
30.2. Point Of Care Infectious Disease Testing Market Company Profiles
- 30.2.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Point Of Care Infectious Disease Testing Market Other Major And Innovative Companies

31.1. Becton Dickinson and Company
31.2. Quest Diagnostics Incorporated
31.3. bioMerieux Societe Anonyme
31.4. QuidelOrtho Corporation
31.5. Bio-Rad Laboratories Inc.
31.6. DiaSorin Societa per Azioni
31.7. Danaher Corporation
31.8. Cue Health Inc.
31.9. Nova Biomedical Corporation
31.10. Seegene Incorporated
31.11. Biosynex Societe Anonyme
31.12. Trivitron Healthcare Private Limited
31.13. EKF Diagnostics Holdings plc
31.14. Trinity Biotech Public Limited Company
31.15. bioLytical Laboratories Inc.

32. Global Point Of Care Infectious Disease Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point Of Care Infectious Disease Testing Market

34. Recent Developments In The Point Of Care Infectious Disease Testing Market

35. Point Of Care Infectious Disease Testing Market High Potential Countries, Segments and Strategies

35.1 Point Of Care Infectious Disease Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Point Of Care Infectious Disease Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Point Of Care Infectious Disease Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer